Jean Jacques Bienaime - Jun 10, 2025 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Director
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Stock symbol
IMNM
Transactions as of
Jun 10, 2025
Transactions value $
$0
Form type
4
Date filed
6/12/2025, 04:52 PM
Previous filing
Jun 6, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BIENAIME JEAN JACQUES Director C/O IMMUNOME, INC., 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL /s/ Sandra Stoneman, Attorney-in-Fact 2025-06-12 0001221590

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Director Stock Option (right to buy) Award $0 +18.9K $0.00 18.9K Jun 10, 2025 Common Stock 18.9K $9.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in four quarterly installments, commencing from June 10, 2025 until the one-year anniversary thereafter, occurring on the same day of each succeeding fiscal quarter, subject to the Reporting Person's continuous service with the Company on each respective vesting date.